CBD

Sipp Industries Announces Distribution Agreement for Patented SinuSave® CBD Nasal Spray

Retrieved on: 
Tuesday, January 23, 2024
Sinusitis, Originality, Partnership, Common, Cannabidiol, OTC, CBD, Pain, Allergy, Marketing, Air pollution, Pharmaceutical industry

SinuSave® CBD Nasal Spray, offering a range of patented CBD nasal spray products in 500mg and 1000mg strengths, is poised to transform the wellness industry.

Key Points: 
  • SinuSave® CBD Nasal Spray, offering a range of patented CBD nasal spray products in 500mg and 1000mg strengths, is poised to transform the wellness industry.
  • SinuSave® CBD is the only all-natural drug-free patented product specifically designed for daily nasal hygiene of its type.
  • "This partnership with SinuSave® represents an exciting leap forward for SIPP Industries," said Jakob Jorgensen, CEO of SIPP Industries.
  • "The SinuSave® CBD Nasal Spray is set to revolutionize how individuals approach nasal health.

Pressure BioSciences Reports New Client Launching Around UltraShear Nanoemulsions Platform with $300,000-plus Product Order

Retrieved on: 
Thursday, January 18, 2024
Professional, Professor, Food, Health, University, Sale, Cosmetics, OTCQB, CBD, Vince, Marketing, Absorption, University of Mississippi

The company’s website and online store are currently under construction, with the initial PrescriptionGrade products slated for Beta testing in March 2024, and fully launching into sales in Q2 2024.

Key Points: 
  • The company’s website and online store are currently under construction, with the initial PrescriptionGrade products slated for Beta testing in March 2024, and fully launching into sales in Q2 2024.
  • VICAR has proudly announced PBIO’s Nano-CBD Topical Spray will be the first product available through their on-line store.
  • Manufactured using PBIO’s patented UltraShear™ technology (UltraShear™ or UST™), PrescriptionGrade Nano-CBD is a revolutionary high-performance product providing ultrafast speed of action and unprecedented effectiveness, in a preservative-free, “green/clean” labeled, sterile-filtered and vialed, all plant-based, highly stable topical product design.
  • Our commitment to excellence extends well beyond the all-important formulation, encompassing iconic branding and streamlined order flow systems.

Enigma Biomedical Group - USA Signs License Agreement with AbbVie for Novel 4R Tau PET Imaging Biomarkers

Retrieved on: 
Thursday, January 18, 2024
Health, Genetics, Other Health, Clinical Trials, Pharmaceutical, Biotechnology, Patient, PET, Ligand, Enigma, Corticobasal degeneration, 4R, PSP, CBD, Acceleration, Therapy, Biomarker, AbbVie, Neurodegenerative disease, EBG, Medical imaging

Enigma Biomedical Group - USA (EBG-USA) today announced it has signed an exclusive license and option agreement with AbbVie for the development and potential commercialization of AbbVie’s next-generation F18 PET imaging biomarkers to assess the presence of four-repeat (4R) tau protein in patients with suspected neurodegenerative disease.

Key Points: 
  • Enigma Biomedical Group - USA (EBG-USA) today announced it has signed an exclusive license and option agreement with AbbVie for the development and potential commercialization of AbbVie’s next-generation F18 PET imaging biomarkers to assess the presence of four-repeat (4R) tau protein in patients with suspected neurodegenerative disease.
  • The 4R tau PET imaging biomarkers hold great promise as important new tools in advancing the understanding of neurodegenerative diseases linked to misfolded 4R tau protein, including progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD).
  • The agreement permits EBG-USA to evaluate AbbVie’s next-generation F18 PET imaging biomarkers.
  • If the evaluations are favorable, EBG-USA has the option to negotiate an exclusive license agreement with AbbVie for the PET ligands.

brelixi® Introduces Fast-Acting + Flavorless Functional Powders In CBD And THC Formats

Retrieved on: 
Thursday, January 25, 2024
Powder, Griffonia, Relaxation, Magnesium, Coffee, CBD, Nano, Cannabis, THC, Phosphorus

NEW YORK, Jan. 25, 2024 /PRNewswire/ -- In a pioneering move that epitomizes brelixi®'s commitment to innovation, the nano-cannabis company is shaking up the scene with the launch of its flavorless + functional fast-acting powders. Available in both THC and CBD formats, this release marks a significant stride toward merging the wellness and cannabis industries.

Key Points: 
  • Available in both THC and CBD formats, this release marks a significant stride toward merging the wellness and cannabis industries.
  • brelixi's flavorless + functional fast-acting powders empower consumers to enjoy the benefits of functional ingredients and cannabis however they'd prefer.
  • These flavorless powders use advanced nano-emulsification for optimized cannabinoid absorption, ensuring increased bioavailability and rapid onset of effects.
  • For relaxation, brelixi's flavorless CBD nano powder provides 20 mgs of CBD per serving, with 30 servings per jar (600 mg) available for $59.99.

CHEERS CANNABIS SETS THEMSELVES APART USING SOLLUM'S LIGHTING SOLUTION

Retrieved on: 
Thursday, January 25, 2024
Research, Wageningen University & Research, LED, Freedom, Cannabinoid, Pressure, CBD, SQDC, Cannabis, THC, Growth, Drug

MONTRÉAL, Jan. 25, 2024 /PRNewswire/ - Sollum®'s first client in the cannabis sector, Cheers Cannabis , looks forward to the precision Sollum's dynamic lighting can offer when it comes to increasing cannabinoid content.

Key Points: 
  • MONTRÉAL, Jan. 25, 2024 /PRNewswire/ - Sollum®'s first client in the cannabis sector, Cheers Cannabis , looks forward to the precision Sollum's dynamic lighting can offer when it comes to increasing cannabinoid content.
  • An experienced and passionate group of growers makes up the Cheers team, specializing in the indoor production of cannabis for both recreational and medical use.
  • Cheers Cannabis will be installing Sollum smart dynamic LED fixtures in one of their six grow rooms.
  • "Our team is constantly looking for ways to innovate in our cannabis production and invest in new technology," says Head of Production for Cheers Cannabis, Kevin Laliberté.

GEN Z'S INTEREST IN THE SOBER CURIOUS MOVEMENT INCREASES 53%, FROM 2023 TO 2024, ACCORDING TO A NEW NCSOLUTIONS ANALYSIS

Retrieved on: 
Tuesday, January 23, 2024
Millennials, Holiday, CPG, THC, CBD, NCS, Social media, Gen, Mental health, Ecosystem, Advertising, Generation Z

Nearly half (45%) of Gen Z say social media is the most effective advertising channel to inform them about new nonalcoholic options.

Key Points: 
  • Nearly half (45%) of Gen Z say social media is the most effective advertising channel to inform them about new nonalcoholic options.
  • The findings are from the latest consumer sentiment survey about the sober curious movement, a follow-up to a similar survey conducted in January 2023.
  • Together, these findings indicate the sober curious movement gained strength over the last year, largely due to interest from younger generations.
  • Seventeen percent of both millennials and Gen Z said they had tried THC and CBD-infused drinks in 2023.

Women-Owned Cannabis Dispensary Opens its Doors in Goleta

Retrieved on: 
Thursday, January 18, 2024
Table, PST, Central Coast, Commerce, Friends, Golden Joystick Awards, CBD, Megan, Human, Cannabis, Food court, MOM, Drug

GOLETA, Calif., Jan. 18, 2024 /PRNewswire/ -- Megan's Organic Market , a wholesome cannabis storefront, has opened in Goleta, California at 5999 Hollister Ave.

Key Points: 
  • GOLETA, Calif., Jan. 18, 2024 /PRNewswire/ -- Megan's Organic Market , a wholesome cannabis storefront, has opened in Goleta, California at 5999 Hollister Ave.
  • The women-owned market has stocked shelves with a curated selection of over 60 high-quality cannabis brands at prices for all budgets.
  • "We are excited to welcome the Goleta community into our unique space where they can safely explore cannabis and embrace its benefits," said Megan Souza, CEO and co-founder at Megan's Organic Market.
  • The Central Coast's beloved cannabis storefront, started in San Luis Obispo and gained a loyal following for its approach unlike other cannabis dispensaries.

Arch Amenities Group Opens Newly Renovated 13,000-Square-Foot Privai Spa + Fitness Center at the Luxury Kimpton EPIC Hotel in Miami

Retrieved on: 
Thursday, January 18, 2024
Acupressure, Arch, Massage, Woman, Health, Holiday, Vibration, Partnership, Magnet, Consciousness, Relaxation, Skin, Rejuvenation, Movement, CBD, Meditation, High-intensity interval training, Medicine, Yoga, Ageing

, Jan. 18, 2024 /PRNewswire/ -- Arch Amenities Group , a full-service, global provider of wellness, amenity management and meeting services for commercial and residential properties, hotels, private clubs and pools, today announced the opening of its first Privai Spa + Fitness Center in a hotel: the 411-room, luxury Kimpton EPIC Hotel in Miami.

Key Points: 
  • , Jan. 18, 2024 /PRNewswire/ -- Arch Amenities Group , a full-service, global provider of wellness, amenity management and meeting services for commercial and residential properties, hotels, private clubs and pools, today announced the opening of its first Privai Spa + Fitness Center in a hotel: the 411-room, luxury Kimpton EPIC Hotel in Miami.
  • The new Privai Spa + Fitness space incorporates product and treatment modalities that reflect the brand's holistic approach to well-being and personalized experiences.
  • Charlotte Prescott, Privai Spa + Fitness Center director, said touchless technology is a key to the facility's identity.
  • Privai Spa + Fitness Center offers memberships to residents of the adjacent EPIC Residences Condo Towers and other local residents.

NarcX+ First to Meet DEA Standards for Destroying Illicit Fentanyl and Rendering It Non-Retrievable

Retrieved on: 
Tuesday, January 16, 2024
Public Policy, Government, Pharmaceutical, Medical Supplies, Health, Law Enforcement, Emergency Services, Hospitals, Public Safety, Other Health, Powder, Forensic science, Oxycodone, DEA, Forensic toxicology, LCMS, Heroin, CBD, Tablet, Prohibition, Law enforcement, THC, Cocaine, Adderall, Drug

NarcX+ has successfully completed the first independent validation, by a 3rd party criminal laboratory, of its kind by testing its effectiveness against illicit fentanyl tablets and powders.

Key Points: 
  • NarcX+ has successfully completed the first independent validation, by a 3rd party criminal laboratory, of its kind by testing its effectiveness against illicit fentanyl tablets and powders.
  • The environmentally safe solution, NarcX+, has been analytically tested using LCMS technology, and proven that after a short amount of time the illicit fentanyl drug is non-detectable and non-retrievable meeting all DEA standards.
  • The Center for Forensic Science Research & Education (CFSRE), a forensic toxicology and chemistry laboratory, conducted a series of analytical tests by adding illicit fentanyl to NarcX+.
  • The tests conducted validate that at 5 minutes illicit fentanyl tablets are completely destroyed and non-retrievable.

1606 Corp. Accounts Skyrocket After December AI ChatBot Launch Leading to Expected Profitability in 2024

Retrieved on: 
Tuesday, January 16, 2024
OTC Markets Group, ISO, CBD, News, Sales

1606 Corp. is leading the charge in AI-driven conversational e-commerce technology by leveraging the collective expertise of its board and harnessing the strengths of existing partnerships.

Key Points: 
  • 1606 Corp. is leading the charge in AI-driven conversational e-commerce technology by leveraging the collective expertise of its board and harnessing the strengths of existing partnerships.
  • 1606 Corp. has successfully developed a groundbreaking AI solution tailored to address the unique customer educational challenges faced by CBD merchants.
  • With a growing number of partners and resellers, we're poised for rapid expansion in 2024," said the Company's CEO, Greg Lambrecht.
  • With these developments, 1606 Corp. confidently anticipates a profitable second quarter in 2024, affirming its position as a leader in AI e-commerce technology.